Related Experiment Videos
Reply to Prim et al., "Is Colistin Susceptibility Testing Finally on the Right Track?"
Matti Karvanen1, Christer Malmberg2, Pernilla Lagerbäck2
1Department of Medical Sciences, Uppsala University, Uppsala, Sweden matti.karvanen@medsci.uu.se.
Antimicrobial Agents and Chemotherapy
|March 29, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Time-Dependent Bias and Prognostic Confounding in Exposure-Response Analysis of Targeted Therapies: Lessons from Sunitinib in Metastatic Renal Cancer.
Clinical pharmacology and therapeutics·2026
Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.
CPT: pharmacometrics & systems pharmacology·2026
Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.
Clinical pharmacokinetics·2026
Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.
NPJ precision oncology·2026
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
When deliberation becomes inefficient.
Acta psychologica·2026
Comprehensive Genomic Profiling Timeliness Beyond Laboratory Turnaround Time: A Patient-Facing Pathway Analysis.
Asia-Pacific journal of clinical oncology·2026
Beyond random splits: A hierarchical benchmark of transferability and reliability in PROTAC activity prediction.
Computational biology and chemistry·2026
California to vote on $16 billion to boost research.
Science (New York, N.Y.)·2026
Risk Assessment in Peacekeeping: Are Visual Sparse Models Transparent?
Risk analysis : an official publication of the Society for Risk Analysis·2026